Clinical Trial Update: Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 safety and preliminary efficacy study of MTS-01 to prevent alopecia induced by whole brain radiotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia

Drugs mentioned

• MTS-01

Snippet

Sponsor: Mitos Pharmaceuticals | Conditions: Alopecia | Phase 2 | Status: TERMINATED